FDA-positive path for sonelokimab in HS, strong VELA data and BLA timing through 2026, plus more. Click for this MLTX update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results